The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 12, 2019

Filed:

Dec. 31, 2012
Applicant:

Cellscript, Llc, Madison, WI (US);

Inventors:

Judith Meis, Fitchburg, WI (US);

Anthony Person, Madison, WI (US);

Cynthia Chin, Madison, WI (US);

Jerome Jendrisak, Middleton, WI (US);

Gary Dahl, Madison, WI (US);

Assignee:

CELLSCRIPT, LLC, Madison, WI (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); A61K 31/7105 (2006.01); C12N 15/87 (2006.01); C12P 19/34 (2006.01); C12N 5/074 (2010.01); C12N 15/10 (2006.01); C12N 5/0793 (2010.01); A61K 33/06 (2006.01); C12P 21/02 (2006.01); C12N 5/077 (2010.01); C12P 19/38 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0066 (2013.01); A61K 31/7105 (2013.01); A61K 33/06 (2013.01); A61K 38/005 (2013.01); A61K 48/0041 (2013.01); C12N 5/0619 (2013.01); C12N 5/0658 (2013.01); C12N 5/0696 (2013.01); C12N 15/1003 (2013.01); C12N 15/1096 (2013.01); C12N 15/87 (2013.01); C12P 19/34 (2013.01); C12P 19/38 (2013.01); C12P 21/02 (2013.01); C12N 2501/60 (2013.01); C12N 2501/602 (2013.01); C12N 2501/603 (2013.01); C12N 2501/604 (2013.01); C12N 2501/605 (2013.01); C12N 2501/606 (2013.01); C12N 2501/608 (2013.01); C12N 2501/73 (2013.01); C12N 2506/1307 (2013.01); C12N 2510/00 (2013.01); C12Y 301/26003 (2013.01);
Abstract

The present invention relates to compositions, kits and methods for making and using RNA compositions comprising in vitro-synthesized ssRNA inducing a biological or biochemical effect in a mammalian cell or organism into which the RNA composition is repeatedly or continuously introduced. In certain embodiments, the invention provides compositions and methods for changing the state of differentiation or phenotype of a human or other vertebrate cell. For example, the present invention provides mRNA and methods for reprogramming cells that exhibit a first differentiated state or phenotype to cells that exhibit a second differentiated state or phenotype, such as to reprogram human somatic cells to pluripotent stem cells.


Find Patent Forward Citations

Loading…